GSK opened the doors to its £300 million Brentford location in 2002 as the biggest single commercial development in the U.K. at the time with four five-story buildings and a 16-story tower block ...

GSK topped the Stoxx Europe 600 index after the pharmaceutical company agreed to pay up to $2.2 billion to settle thousands of U.S. lawsuits over claims its discontinued heartburn medicine Zantac ...

GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on Wednesday.

Drugs giant GSK is set to move its global headquarters back to central London, ending more than two decades at its Brentford base. Around 3,000 employees will work from The Earnshaw building on ...

GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on ...

GSK said that its vaccine against RSV reduced the risk of developing lower respiratory tract disease by 82.6% in a large trial. Photo: kenzo tribouillard/Agence France-Presse/Getty Images ...

GSK’s 2,000 in-house vaccine R&D scientists engaged in more than 150 scientific collaborations in 2022, producing more than 200 publications—partnerships are key to the growth of GSK.

GSK has paid out $100 million cash to Mersana Therapeutics for the potential to add a second antibody-drug conjugate (ADC) to its portfolio, which currently consists of approved multiple myeloma dr ...